2-s-cysteinyldopa has been researched along with Malignant Melanoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujita, M; Fukada, E; Hanawa, S; Morishima, T; Saito, M | 1 |
| Carstam, R; Hansson, C; Lindbladh, C; Rorsman, H; Rosengren, E | 1 |
| Castagnoli, N; Epstein, WL; Fukuyama, K; Gellin, GA; Halldin, MM; Kawashima, T | 1 |
3 other study(ies) available for 2-s-cysteinyldopa and Malignant Melanoma
| Article | Year |
|---|---|
[High-performance liquid chromatographic determination of urinary 5-S, 2-S-, 6-S-cysteinyldopa and 2,5-S,S-dicysteinyldopa (author's transl)].
Topics: Chromatography, High Pressure Liquid; Cysteinyldopa; Dihydroxyphenylalanine; Humans; Melanoma | 1982 |
Dopaquinone addition products in cultured human melanoma cells.
Topics: Benzoquinones; Cell Line; Cysteinyldopa; Dihydroxyphenylalanine; Humans; Melanoma; Pigmentation | 1987 |
Stimulation of pheomelanogenesis in cultured B16 melanoma cells by 4-tertiary butylcatechol.
Topics: Animals; Catechols; Cell Line; Chromatography, High Pressure Liquid; Cysteinyldopa; Dose-Response Relationship, Drug; Glutathione; Kinetics; Levodopa; Melanins; Melanoma; Mice | 1985 |